Approvals/TGA/XIGDUO XR 10/500 dapagliflozin 10 mg (as propanediol monohydrate) / metformin hydrochloride 500 mg modified release tablets blister pack

Approved

STANDARD

XIGDUO XR 10/500 dapagliflozin 10 mg (as propanediol monohydrate) / metformin hydrochloride 500 mg modified release tablets blister pack

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 29, 2025
Approval ID: c1a536bdd198e6bd
Company: AstraZeneca Pty Ltd
Type: Standard

Approval Details

Approval Id: c1a536bdd198e6bd
Product Name: XIGDUO XR 10/500 dapagliflozin 10 mg (as propanediol monohydrate) / metformin hydrochloride 500 mg modified release tablets blister pack
Artg Id: 211294
Artg Name: XIGDUO XR 10/500 dapagliflozin 10 mg (as propanediol monohydrate) / metformin hydrochloride 500 mg modified release tablets blister pack
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2014-07-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/27503a567d34944857daddd07bbf963e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7c927bdea9504cd942993ae6972e50cf.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

c1a536bdd198e6bd

Type

Standard

Back to TGA Approvals